Adequate supply for patients in danger as regulators continue to thwart patient access, available medicine
/EIN News/ —
ALBUQUERQUE, N.M., July 27, 2020 (GLOBE NEWSWIRE) — New Mexico’s medical cannabis patients are at risk of running out of medicine due to the effects of COVID-19 and statewide shutdowns, according to a recent report published by O’Donnell Economics. Ultra Health, New Mexico’s #1 Cannabis Company, has felt the effects of COVID-19 with unprecedented demand and patient sales since March 2020.
“The pandemic substantially increased demand for medical cannabis in New Mexico, worsening the state’s medical cannabis shortage, driving up price, and negatively impacting patients,” the report, produced by Kelly O’Donnell of O’Donnell Economics, stated.
The medical cannabis shortage highlights a significant deficiency in New Mexico’s public health infrastructure.
The increased demand can be attributed to cannabis patients being a medically vulnerable population in New Mexico. Some patients are immunocompromised, putting them at greater risk of contracting COVID-19. A majority of patients have qualifying conditions and the symptoms are likely to be exacerbated by the effects of the pandemic such…